New Millennium Group’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$17K Hold
900
0.01% 176
2025
Q3
$13.1K Hold
900
0.01% 201
2025
Q2
$17.6K Hold
900
0.01% 159
2025
Q1
$16K Hold
900
0.01% 166
2024
Q4
$19.3K Hold
900
0.01% 162
2024
Q3
$28.1K Hold
900
0.02% 125
2024
Q2
$14K Buy
+900
New +$10.9K 0.01% 163
2024
Q1
Sell
-900
Closed -$10.8K 122
2023
Q4
$10.8K Hold
900
0.01% 196
2023
Q3
$6.3K Hold
900
0.01% 198
2023
Q2
$7.65K Hold
900
0.01% 187
2023
Q1
$8.23K Hold
900
0.01% 198
2022
Q4
$10.3K Hold
900
0.01% 191
2022
Q3
$15K Hold
900
0.02% 159
2022
Q2
$19K Buy
+900
New +$25K 0.02% 154

Other funds holding CDNA

New Millennium Group's CDNA Position: Q4 2025 in Review

New Millennium Group held its CareDx (CDNA) position steady in Q4 2025 at 900 shares worth $17K. The position accounts for 0.01% of the portfolio, ranked #176.

New Millennium Group first reported a position in CDNA in Q2 2022 and has held it in 14 quarters since. The position peaked at $28.1K in Q3 2024. 200 funds tracked by Wall St. Rank hold CDNA as of Q4 2025.

  • New Millennium Group held 900 shares of CareDx worth $17K as of Q4 2025.
  • New Millennium Group left its CareDx share count unchanged in Q4 2025.
  • CareDx made up 0.01% of New Millennium Group's portfolio in Q4 2025, its #176 holding.
  • New Millennium Group first reported a position in CareDx in Q2 2022 and has held it in 14 quarters since.
  • New Millennium Group's CareDx position peaked at $28.1K in Q3 2024.
  • 200 funds tracked by Wall St. Rank held CareDx as of Q4 2025.

Based on New Millennium Group's 13F filing for Q4 2025, filed 6 Feb 2026.